Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

IL-4 and IL-13 drive atopic dermatitis pathology by regulating sex steroid hormone synthesis

Oct. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

JUN identified as a crucial regulator of pathological skin scarring via CD36

Sep. 15, 2021

Genfleet Therapeutics discovers RIP-1 inhibitors

Sep. 9, 2021

LEO Pharma's novel IL-17A/IL-17AR interaction modulator for the oral treatment of psoriasis

Sep. 3, 2021

New melanocortin receptor modulators presented by Palatin Technologies

Sep. 2, 2021

Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint

Aug. 26, 2021

Data presented for Almirall's JAK inhibitor LAS-200019

Aug. 26, 2021

Jupiter Wellness submits pre-IND meeting request for JW-100 for eczema

Aug. 24, 2021

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Aug. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...